share_log

Envol Biomedical Selects Xybion's Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations

Envol Biomedical Selects Xybion's Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations

Envol Biomedical 选择 Xybion 的临床前黄金标准 LIMS Pristima 来实现实验室运营的数字化
Accesswire ·  04/16 09:00

Xybion's Preclinical LIMS Unifies and Enhances Laboratory Efficiency and Data Integrity for EnvolBio's CRO operations.

Xybion的临床前LIMS统一并增强了EnvolBio的CRO运营的实验室效率和数据完整性。

PRINCETON, NJ / ACCESSWIRE / April 15, 2024 / Xybion Digital announced today its partnership with EnvolBio to digitize lab operations for end-to-end non-clinical process standardization, streamline data for faster lab operation, manage quality, improve data integrity and compliance. This end-to-end preclinical gold standard solution helps the R&D teams with the ability to seamlessly perform study planning, cost management, protocol creation, study execution, data management, reporting, and regulatory submissions of non-clinical research and development studies.

新泽西州普林斯顿/ACCESSWIRE/2024年4月15日/Xybion Digital今天宣布与EnvolBio合作,将实验室运营数字化,实现端到端非临床过程标准化,简化数据以加快实验室运营,管理质量,提高数据完整性和合规性。这种端到端的临床前黄金标准解决方案可帮助研发团队无缝执行非临床研发研究的研究规划、成本管理、方案创建、研究执行、数据管理、报告和监管申报。

As a world-leading, research-driven CRO, EnvolBio creates value through specialized primate studies and preclinical and clinical pharmacology services for drug discovery, toxicology, and clinical trials. "The nonclinical lab processes and data management are a critical part of EnvolBio's development, and the enhanced processes will make studies a lot more efficient. EnvolBio is excited to partner with Xybion and its end-to-end, fully unified solution, which will support us to run nearly the entire process from a single system. This improves the business user experience significantly, offers more flexibility, and simplifies the IT ecosystem through a single platform instead of operating multiple systems," says Jacob McDonald, CEO of EnvolBio, responsible for this program.

作为世界领先的、以研究为导向的CRO,EnvolBio通过专门的灵长类研究以及药物发现、毒理学和临床试验的临床前和临床药理学服务来创造价值。“非临床实验室流程和数据管理是EnvolBio开发的关键部分,增强的流程将大大提高研究效率。EnvolBio很高兴与Xybion及其端到端、完全统一的解决方案合作,这将支持我们从单个系统运行几乎整个流程。这极大地改善了企业用户体验,提供了更大的灵活性,并通过单一平台而不是操作多个系统简化了IT生态系统。” 负责该计划的EnvolBio首席执行官雅各布·麦克唐纳说。

The Pristima LIMS SaaS software offers a complete digital lab environment:

Pristima LIMS SaaS 软件提供了完整的数字实验室环境:

  • Protocol Management
  • Planning, Cost and Resource Management
  • Toxicology
  • Pathology and Digital Pathology
  • Histology
  • Veterinary Management, IACUC
  • Colony Management
  • Pharmacy
  • Master Schedule, audits, non-conformance, CAPA
  • CDSIC SEND
  • Historical Controls Database (HCDB), Reporting and Analytics.
  • Lab Datalake and Artificial Intelligence
  • 协议管理
  • 规划、成本和资源管理
  • 毒理学
  • 病理学和数字病理学
  • 组织学
  • 兽医管理,IACUC
  • 殖民地管理
  • 药房
  • 总进度、审计、不合规、CAPA
  • CDSIC 发送
  • 历史控制数据库 (HCDB)、报告和分析。
  • 实验室数据湖和人工智能

Mr. Kamal Biswas, President and COO of Xybion, says, "We are super excited to start this partnership. Xybion's LIMS creates an end-to-end digital laboratory execution environment not only for internal EnvolBio existing labs, but it also creates a future expansion path to streamline workflows, automation, data management, and artificial intelligence solutions. I'm very happy to support Jacob and his team to achieve their lab digitization goals."

Xybion总裁兼首席运营官卡玛尔·比斯瓦斯先生说:“我们非常高兴开始这种合作伙伴关系。Xybion 的 LIMS 不仅为内部的 EnvolBio 现有实验室创建了端到端的数字实验室执行环境,而且还为简化工作流程、自动化、数据管理和人工智能解决方案开辟了未来的扩展路径。我很高兴支持雅各布和他的团队实现他们的实验室数字化目标。”

"We are exceptionally proud to have been selected by EnvolBio as their partner for the digital acceleration of lab operations. This win bolsters Xybion Digital's track record as a trusted partner to large multinationals operating in the life sciences industry," said Dr. Pradip Banerjee, Chairman and CEO of Xybion Digital.

“我们非常自豪地被EnvolBio选为他们加速实验室运营的数字化合作伙伴。这一胜利巩固了Xybion Digital作为生命科学行业大型跨国公司值得信赖的合作伙伴的往绩。” Xybion Digital董事长兼首席执行官普拉迪普·巴纳吉博士说。

About Xybion Digital Inc.

关于 Xybion Digital Inc.

Xybion is a leading software solution and consulting company dedicated to helping corporations solve business problems and create new capabilities. Through intelligently designed systems and business processes, we help companies become more efficient, reduce costs, and manage compliance, regulatory adherence, and risk. Serving more than 350 customers in 35 countries, we have the global scale and expertise to bring employees around the world to help companies in life sciences, healthcare, manufacturing, workplace health, and government. We put our expertise into action every day to help companies transform the digital workplace. Our unique solutions focus on integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, GRC, quality management, predictive compliance, content management, and systems validation. Since its founding in 1977, Xybion has supported most of the top 20 global life sciences companies through software, services, and consulting.

Xybion 是一家领先的软件解决方案和咨询公司,致力于帮助企业解决业务问题和创建新功能。通过智能设计的系统和业务流程,我们帮助公司提高效率、降低成本并管理合规性、监管遵守情况和风险。我们为35个国家的350多家客户提供服务,拥有全球规模和专业知识,可以将员工带到世界各地,为生命科学、医疗保健、制造、工作场所健康和政府领域的公司提供帮助。我们每天都将我们的专业知识付诸实践,以帮助公司改造数字化工作场所。我们独特的解决方案侧重于综合临床前实验室管理、早期药物发现、数字实验室解决方案、监管合规、GRC、质量管理、预测合规性、内容管理和系统验证。自 1977 年成立以来,Xybion 通过软件、服务和咨询为全球前 20 家生命科学公司中的大多数提供了支持。

About Envol BioMedical

关于 Envol 生物医学

Envol Biomedical offers preclinical pharmacology and toxicology services for drug discovery and development in support of small molecules, gene therapy, and biologics. Envol Biomedical has access to the largest population of readily available naïve and non-naïve non-human primates (old-world and new world) in the continental U.S. Envol Biomedical provides cost-effective quality pharmacokinetic and pharmacodynamic studies with extremely fast turn-around time. Envol Biomedical is dedicated to the on-time delivery of study samples and study reports (standard and specific study protocols).

Envol Biomedical为药物发现和开发提供临床前药理学和毒理学服务,以支持小分子、基因疗法和生物制剂。Envol Biomedical可以接触到美国大陆最大的现成天真和非天真的非人类灵长类动物(旧世界和新世界)。Envol Biomedical以极快的周转时间提供具有成本效益的高质量药代动力学和药效学研究。Envol Biomedical 致力于按时交付研究样本和研究报告(标准和特定研究协议)。

Contacts:

联系人:

Media
Joseph Kalina
Xybion Digital
609-512-5790 x 316
jkalina@Xybion.com

媒体
约瑟夫·卡利纳
Xybion Digital
609-512-5790 x 316
jkalina@Xybion.com

SOURCE: Xybion Digital Inc.

来源:Xybion Digital Inc.


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发